These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 3385459
1. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol. Horwitz RI, Viscoli CM, Merino M, Brennan TA, Flannery JT, Robboy SJ. J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459 [Abstract] [Full Text] [Related]
2. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks. Hanselaar A, van Loosbroek M, Schuurbiers O, Helmerhorst T, Bulten J, Bernhelm J. Cancer; 1997 Jun 01; 79(11):2229-36. PubMed ID: 9179071 [Abstract] [Full Text] [Related]
3. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic]. van Dijck JA, Doorduijn Y, Bulten JH, Verloop J, Massuger LF, Kiemeney BA. Ned Tijdschr Geneeskd; 2009 Jun 01; 153():A366. PubMed ID: 19857300 [Abstract] [Full Text] [Related]
4. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Herbst AL, Cole P, Colton T, Robboy SJ, Scully RE. Am J Obstet Gynecol; 1977 May 01; 128(1):43-50. PubMed ID: 851158 [Abstract] [Full Text] [Related]
6. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Herbst AL, Anderson D. Semin Surg Oncol; 1990 May 01; 6(6):343-6. PubMed ID: 2263810 [Abstract] [Full Text] [Related]
9. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. J Med Assoc State Ala; 1977 Mar 01; 46(9):39-41. PubMed ID: 845523 [No Abstract] [Full Text] [Related]
12. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Huo D, Anderson D, Palmer JR, Herbst AL. Gynecol Oncol; 2017 Sep 01; 146(3):566-571. PubMed ID: 28689666 [Abstract] [Full Text] [Related]
13. The current status of the DES-exposed population. Herbst AL. Obstet Gynecol Annu; 1981 Sep 01; 10():267-78. PubMed ID: 7024873 [Abstract] [Full Text] [Related]
14. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Herbst AL, Cole P, Norusis MJ, Welch WR, Scully RE. Am J Obstet Gynecol; 1979 Dec 01; 135(7):876-86. PubMed ID: 507130 [Abstract] [Full Text] [Related]
16. Management of the adolescent girl exposed in utero to DES. Gerbie MV. Pediatr Ann; 1981 Dec 01; 10(12):23-6. PubMed ID: 7335401 [Abstract] [Full Text] [Related]
17. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure. Clement R, Guilbaud E, Barrios L, Rougé-Maillart C, Jousset N, Rodat O. Med Sci Law; 2014 Oct 01; 54(4):219-29. PubMed ID: 24534146 [Abstract] [Full Text] [Related]